ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 72 filers reported holding ALLOVIR INC in Q2 2024. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,706,981 | -61.6% | 2,511,004 | +21.5% | 0.02% | -63.5% |
| Q3 2023 | $4,443,332 | -24.4% | 2,066,666 | +19.6% | 0.05% | -25.7% |
| Q2 2023 | $5,875,207 | +49.1% | 1,728,002 | +72.8% | 0.07% | +29.6% |
| Q1 2023 | $3,940,000 | -29.3% | 1,000,000 | -8.0% | 0.05% | -28.0% |
| Q4 2022 | $5,576,772 | -35.0% | 1,087,090 | -0.0% | 0.08% | -37.5% |
| Q3 2022 | $8,577,000 | +102.3% | 1,087,093 | 0.0% | 0.12% | +84.6% |
| Q2 2022 | $4,240,000 | -42.2% | 1,087,093 | 0.0% | 0.06% | -45.4% |
| Q1 2022 | $7,338,000 | -47.8% | 1,087,093 | 0.0% | 0.12% | -41.1% |
| Q4 2021 | $14,067,000 | -61.5% | 1,087,093 | -25.5% | 0.20% | -66.2% |
| Q3 2021 | $36,576,000 | +29.9% | 1,459,548 | +2.4% | 0.60% | +13.7% |
| Q2 2021 | $28,147,000 | +1.9% | 1,425,885 | +20.8% | 0.52% | -14.2% |
| Q1 2021 | $27,610,000 | -30.9% | 1,179,934 | +13.5% | 0.61% | -42.3% |
| Q4 2020 | $39,973,000 | +22.0% | 1,039,880 | -12.7% | 1.06% | -1.2% |
| Q3 2020 | $32,753,000 | – | 1,191,014 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $54,367,000 | 0.96% |
| Redmile Group, LLC | 1,943,587 | $45,480,000 | 0.64% |
| Woodline Partners LP | 1,179,934 | $27,610,000 | 0.61% |
| EcoR1 Capital, LLC | 447,012 | $10,460,000 | 0.46% |
| Samsara BioCapital, LLC | 82,336 | $1,927,000 | 0.36% |
| Ikarian Capital, LLC | 200,000 | $4,680,000 | 0.16% |
| CNA FINANCIAL CORP | 11,705 | $274,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,006,142 | $23,544,000 | 0.08% |
| Virtus ETF Advisers LLC | 7,478 | $175,000 | 0.07% |
| Focus Financial Network, Inc. | 24,941 | $583,619 | 0.07% |